dc.creatorBrito, AS
dc.creatorArimateia, DS
dc.creatorSouza, LR
dc.creatorLima, MA
dc.creatorSantos, VO
dc.creatorMedeiros, VP
dc.creatorFerreira, PA
dc.creatorSilva, RA
dc.creatorFerreira, CV
dc.creatorJusto, GZ
dc.creatorLeite, EL
dc.creatorAndrade, GPV
dc.creatorOliveira, FW
dc.creatorNader, HB
dc.creatorChavante, SF
dc.date2008
dc.date37196
dc.date2014-11-15T14:54:13Z
dc.date2015-11-26T16:11:45Z
dc.date2014-11-15T14:54:13Z
dc.date2015-11-26T16:11:45Z
dc.date.accessioned2018-03-28T23:00:15Z
dc.date.available2018-03-28T23:00:15Z
dc.identifierBioorganic & Medicinal Chemistry. Pergamon-elsevier Science Ltd, v. 16, n. 21, n. 9588, n. 9595, 2008.
dc.identifier0968-0896
dc.identifierWOS:000260134400020
dc.identifier10.1016/j.bmc.2008.09.020
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/77806
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/77806
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/77806
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1267165
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionThe anti-inflammatory properties of a heparin-like compound from the shrimp Litopenaeus vannamei are related. Besides reducing significantly (p < 0.001) the influx of inflammatory cells to injury site in a model of acute inflammation, shrimp heparin-like compound was able to reduce the matrix metalloproteinase (MMPs) activity in the peritoneal lavage of inflamed animals. Moreover, this compound also reduced almost 90% the activity of MMP-9 secreted by human activated leukocytes. Negligible anti-coagulant activities in aPPT assay and a poor bleeding potential make this compound a better alternative than mammalian heparin as a possible anti-inflammatory drug. (C) 2008 Elsevier Ltd. All rights reserved.
dc.description16
dc.description21
dc.description9588
dc.description9595
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.languageen
dc.publisherPergamon-elsevier Science Ltd
dc.publisherOxford
dc.publisherInglaterra
dc.relationBioorganic & Medicinal Chemistry
dc.relationBioorg. Med. Chem.
dc.rightsfechado
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.sourceWeb of Science
dc.subjectGlycosaminoglycans
dc.subjectCrustacean heparin-like compound
dc.subjectAnti-inflammatory activity
dc.subjectHeparin
dc.subjectAnticoagulant activity
dc.subjectInvertebrate
dc.subjectHemorrhagic activity
dc.subjectLitopenaeus vannamei
dc.subjectMatrix metalloproteinases
dc.subjectEscherichia-coli K5
dc.subjectTransmigration In-vitro
dc.subjectP-selectin
dc.subjectAnomalocardia-brasiliana
dc.subjectMatrix Metalloproteinases
dc.subjectCapsular Polysaccharide
dc.subjectAntithrombotic Agent
dc.subjectAcute-inflammation
dc.subjectEndothelial-cells
dc.subjectSulfate
dc.titleAnti-inflammatory properties of a heparin-like glycosaminoglycan with reduced anti-coagulant activity isolated from a marine shrimp
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución